{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T14:36:54Z","timestamp":1791038214894,"version":"4.1.0"},"reference-count":9,"publisher":"Oxford University Press (OUP)","issue":"1","license":[{"start":{"date-parts":[[1994,7,1]],"date-time":"1994-07-01T00:00:00Z","timestamp":773020800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[1994,7,1]]},"abstract":"<jats:title>Summary<\/jats:title>\n               <jats:p>DNA from formalin-fixed and paraffin-processed samples from 100 melanocytic lesions (39 malignant melanomas, 18 cases of dysplastic naevi, and 43 congenital naevi) was extracted, and the sequences around codons 12\/13 and 61 of the N-ras oncogene were amplified using the polymerase chain reaction. The amplified product was then analysed both by dot-blotting and by direct sequencing for point mutations. By the dot-blotting technique, mutations were seen in 18 of 100 lesions. These were in one of five distant metastases (20%), in one of three nodal metastases (33%), in four of 31 (13%) primary melanomas, in none of 18 dysplastic naevi, and in 12 of 43 (28%) congenital naevi, all at codon 61. On direct sequencing, nine of 18 mutations were confirmed, in two of 31 (6%) primary tumours, one distant metastasis, and six of 43 (14%) congenital naevi.<\/jats:p>\n               <jats:p>Of the 23 superficial spreading melanomas examined, eight were on sun-exposed skin. A superficial spreading melanoma, in which the N-ras mutation at codon 61 was confirmed, was on non-exposed skin, and an unconfirmed mutation was from an exposed site. One of three nodular melanomas with a confirmed mutation was on a light-exposed site, and the other two nodular melanomas were from non-exposed areas. All four lentigo maligna melanomas were from exposed sites, and one of these had an unconfirmed mutation. The only acral lentiginous melanoma, which had no mutation, was from a sun-exposed area. Ten of the 43 congenital or early onset naevi were on sun-exposed sites; six unconfirmed and five confirmed mutations were from lesions on non-sun-exposed sites (5\/33; 15%), and one confirmed mutation was from a lesion on a sun-exposed area (1\/10; 10%).<\/jats:p>\n               <jats:p>Our results do not, therefore, support the hypothesis that N-ras mutations are specifically associated with primary melanomas arising on continually sun-exposed skin. The overall pattern suggests that N-ras mutations in isolation in melanocytic lesions are not frequent. This is the first report of N-ras mutations in congenital\/early onset melanocytic naevi, and shows a relatively high incidence in comparison with that observed in melanomas in this study.<\/jats:p>","DOI":"10.1111\/j.1365-2133.1994.tb08460.x","type":"journal-article","created":{"date-parts":[[2006,7,30]],"date-time":"2006-07-30T19:36:12Z","timestamp":1154288172000},"page":"72-77","source":"Crossref","is-referenced-by-count":81,"title":["Point mutations in the N-<i>ras<\/i> oncogene in malignant melanoma and congenital naevi"],"prefix":"10.1093","volume":"131","author":[{"given":"J.","family":"CARR","sequence":"first","affiliation":[{"name":"Department of Dermatology. University of Glasgow. Glasgow G12 8QQ, U.K."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.M.","family":"MACKIE","sequence":"additional","affiliation":[{"name":"Department of Dermatology. University of Glasgow. Glasgow G12 8QQ, U.K."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[1994,7,1]]},"reference":[{"key":"2023013105391763400_b1","first-page":"1363","article-title":"Analysis of ras oncogenes in malignant melanoma and precursor lesions: correlation of point mutations with differentiation phenotype","volume":"4","author":"Albino","year":"1989","journal-title":"Oncogene"},{"key":"2023013105391763400_b2","first-page":"3114","article-title":"N-ras mutations in human cutaneous melanoma from sun-exposed body sites","volume":"9","author":"Van't Veer","year":"1989","journal-title":"Mol Cell Biol"},{"key":"2023013105391763400_b3","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1136\/jcp.39.2.189","article-title":"Proposed alternative terminology and subclassification of so-called \u2018dysplastic naevi\u2019","volume":"39","author":"Seywright","year":"1986","journal-title":"J Clin Pathol"},{"key":"2023013105391763400_b4","doi-asserted-by":"crossref","first-page":"1555","DOI":"10.1136\/bmj.292.6535.1555","article-title":"Benign melanocytic naevi as a risk factor for malignant melanoma","volume":"292","author":"Swerdlow","year":"1986","journal-title":"Br Med J"},{"key":"2023013105391763400_b5","volume-title":"Malignant Melanoma, Clinical and Histological Diagnosis","author":"McGovern","year":"1976"},{"key":"2023013105391763400_b6","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1084\/jem.167.1.225","article-title":"Detection of human papilloma virus in paraffin-embedded tissue using the polymerase chain reaction","volume":"167","author":"Shibata","year":"1988","journal-title":"J Exp Med"},{"key":"2023013105391763400_b7","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1126\/science.2448875","article-title":"Primer-directed enzymatic amplification of DNA with a thermostable DNA polymerase","volume":"239","author":"Saiki","year":"1988","journal-title":"Science"},{"key":"2023013105391763400_b8","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/0378-1119(86)90335-5","article-title":"A dot-blot screening procedure for mutated ras oncogenes using synthetic oligodeoxynucleotides","volume":"50","author":"Verlaan-de Vries","year":"1986","journal-title":"Gene"},{"key":"2023013105391763400_b9","doi-asserted-by":"crossref","first-page":"5463","DOI":"10.1073\/pnas.74.12.5463","article-title":"DNA sequencing with chain-terminating inhibitors","volume":"74","author":"Sanger","year":"1977","journal-title":"Proc Natl Acad Sci USA"}],"container-title":["British Journal of Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1365-2133.1994.tb08460.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/academic.oup.com\/bjd\/article-pdf\/131\/1\/72\/48958357\/bjd0072.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/bjd\/article-pdf\/131\/1\/72\/48958357\/bjd0072.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,2,14]],"date-time":"2023-02-14T14:03:37Z","timestamp":1676383417000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/bjd\/article\/131\/1\/72\/6680734"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1994,7,1]]},"references-count":9,"journal-issue":{"issue":"1","published-online":{"date-parts":[[1994,7,1]]},"published-print":{"date-parts":[[1994,7,1]]}},"URL":"https:\/\/doi.org\/10.1111\/j.1365-2133.1994.tb08460.x","relation":{},"ISSN":["1365-2133","0007-0963"],"issn-type":[{"value":"1365-2133","type":"electronic"},{"value":"0007-0963","type":"print"}],"subject":[],"published-other":{"date-parts":[[1994,7,1]]},"published":{"date-parts":[[1994,7,1]]}}}